Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03884101
Brief Title: Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) (LEAP-001)

First Submitted : March 19, 2019
First Submitted that Met QC Criteria : March 19, 2019
First Posted : March 21, 2019

Last Update Submitted that Met QC Criteria : March 24, 2021
Last Update Posted : March 26, 2021